Related Experiment Video
Updated: May 1, 2026

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Differences in vascular nitric oxide and endothelium-derived hyperpolarizing factor bioavailability in blacks and
Muhiddin A Ozkor1, Ayaz M Rahman1, Jonathan R Murrow1
1From the Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA (M.A.O., A.M.R., J.R.M., N.K., S.H., A.A.Q.); and Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA (J.L., A.M.).
Vascular nitric oxide (NO) bioavailability is lower in Black individuals compared to White individuals. Endothelium-derived hyperpolarizing factor (EDHF) partially compensates for reduced NO during vasodilation in Black individuals.
Area of Science:
- Cardiovascular Physiology
- Vascular Biology
- Racial Differences in Health
Background:
- Previous studies suggest abnormalities in nitric oxide (NO) bioavailability in Black populations.
- The role of endothelium-derived hyperpolarizing factor (EDHF) and its interplay with NO in vasodilation between racial groups remains unclear.
- This study investigates potential differences in NO and EDHF bioavailability and their impact on physiological vasodilation in healthy Black and White individuals.
Purpose of the Study:
- To determine if differences exist in nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF) bioavailability between Black and White individuals.
- To assess how these potential differences affect resting and stimulus-mediated vasodilation.
- To test the hypothesis that vascular NO and EDHF bioavailability varies between racial groups at rest and during pharmacological and physiological vasodilation.
Main Methods:
- Plethysmography was used to measure forearm blood flow in 74 White and 86 Black subjects.
- Nitric oxide (NO) bioavailability was inhibited using N(G)-monomethyl-L-arginine.
- Endothelium-derived hyperpolarizing factor (EDHF) was inhibited using tetraethylammonium to block K(+) Ca channels.
- Vasodilation was assessed at rest and during stimulation with bradykinin, acetylcholine, sodium nitroprusside, and exercise.
Main Results:
- Resting forearm blood flow reduction was greater with NO inhibition in White subjects compared to Black subjects.
- Overall vasodilation in response to bradykinin, acetylcholine, and sodium nitroprusside was lower in Black subjects than in White subjects.
- NO inhibition significantly impacted vasodilation more in White subjects during bradykinin, acetylcholine, and exercise challenges.
- EDHF inhibition showed lower impact in Black subjects with bradykinin but higher impact during exercise and acetylcholine challenges.
Conclusions:
- The contribution of nitric oxide (NO) to resting and stimulus-mediated vasodilator tone is greater in White individuals compared to Black individuals.
- Endothelium-derived hyperpolarizing factor (EDHF) plays a compensatory role for reduced NO bioavailability during exercise and acetylcholine-mediated vasodilation in Black individuals.
- Healthy Black individuals exhibit preserved EDHF function alongside reduced NO bioavailability and sensitivity, characterizing their vascular physiology.
Related Concept Videos
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Bioavailability: Influencing Factors
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Factors Affecting Drug Distribution: Organ Perfusion Rate
Perfusion rate-limited distribution relies on the...

